Description BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found naturally in human gastric juice, studied extensively in preclinical research for its cytoprotective properties and role in angiogenesis and cellular repair mechanisms
Novo Nordisk filed for FDA approval of CagriSema (the cagrilintide plus semaglutide combination) in late 2025, but the standalone compound has not been submitted for approval
Use in Peptide Reconstitution Bacteriostatic water is compatible with the majority of peptides sold on this site including BPC-157, TB-500, GHK-Cu, Ipamorelin, Tesamorelin, Semax, Selank, MOTS-C, Kisspeptin-10, and MT2
Sleep Cycle Regulation chat 24/7 Customer Support labs Lab tested for purity & quality local_shipping Ships from Canada within 24 hours Free shipping on orders $300 & up Automatically applied at checkout Canada's only domestic premium peptide manufacturer Polar Peptides is Canada's only domestic manufacturer and supplier of premium research peptides, with production and fulfillment handled in Canada
Storage: Store at -20C or lower, protected from light and moisture
A combination therapy using cord blood mononuclear cells (CBMNCs) and umbilical cord MSCs showed greater improvements than single-cell therapy alone , with no serious safety concerns reported
